Paris, France, 27th April 2022 – Coave Therapeutics will be presenting an abstract at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held in Denver, Colorado 1-4 May 2022. The meeting will also be available for virtual attendees 11-12 May.
The poster will demonstrate Coave’s AAV-mediated human PDE6B gene therapy as a valid strategy to prevent photoreceptor degeneration in a Retinitis Pigmentosa model.
Details of the poster presentation:
Title: AAV-mediated hPDE6B gene therapy preserves retinal function in rd10 mice
Poster Session: Gene Therapy and Gene Editing for Ocular Disorders
Date: Sunday 1 May
Time: 19:15 BST
Presenter: Gaelle Lefevre